Dr. David Musselman

As a board-certified interventional cardiologist, Dr. Banerjee is internationally recognized for his expertise in minimally invasive treatments of coronary artery disease, peripheral artery disease and transcatheter aortic valve replacement. He is currently serving as the Paul J. Thomas Endowed Chair in Cardiology and chief of cardiovascular research and innovation for Baylor Scott & White Heart and Vascular Services-Dallas. Dr. Banerjee is the editor-in-chief of the American Journal of Cardiology, one of the premier cardiology journals in the world. He also serves as one of the founding directors of the Cardiovascular Innovations Foundation. He has led many landmark clinical trials, published over 450 peer-reviewed manuscripts, and is an invited faculty at national and international cardiovascular conferences. Dr. Banerjee is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Peripheral Artery Disease, Atherosclerosis, Coronary Heart Disease, Atherectomy, and Percutaneous Coronary Intervention (PCI). Dr. Banerjee is board certified in Interventional Cardiology- American Board Of Internal Med/Interventional Cardiology, Cardiovascular Disease- American Board Of Internal Med/Cardiovascular Disease, Interventional Cardiology- American Board Of Internal Medicine/Interventional Cardiology, Cardiovascular Disease- American Board Of Internal Medicine/Cardiovascular Disease, Cardiovascular Disease- American Board Of Internal Medicine - Cardiovascular Disease, Interventional Cardiology- American Board Of Internal Medicine - Interventional Cardiology, Cardiovascular Disease- American Board Of Internal Medicine, and Interventional Cardiology- American Board Of Internal Medicine.

Dr. Stoler is board-certified by the American Board of Internal Medicine in Interventional Cardiology. He is the Co-Medical Director of Cardiology and the Medical Director of the Cardiac Catheterization Lab at Baylor Heart and Vascular Hospital. He was appointed Clinical Professor of Medicine, Department of Internal Medicine at Texas A&M Health Science Center College of Medicine. He has published multiple cardiology-related articles in peer-reviewed medical journals and books, and he continues to be a principal investigator in many national clinical trials. After receiving his undergraduate and medical degree from Duke University, Dr. Stoler served his internship and residency in Internal Medicine at University of Texas Southwestern Medical Center in Dallas. He completed his fellowship in Cardiology and Interventional Cardiology at Beth Israel Hospital, Harvard Medical School in Boston. Dr. Stoler is recognized as a Fellow of the American College of Cardiology and The Society for Cardiovascular Angiography and Interventions. He is an active member of Dallas County Medical Society and Texas Medical Association. His professional interest and expertise lie in the various percutaneous treatments for coronary and structural heart disease. Publication. Dr. Stoler is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Coronary Heart Disease, Heart Attack, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Stoler is board certified in Interventional Cardiology- American Board Of Internal Med/Interventional Cardiology, Interventional Cardiology- American Board Of Internal Med - Interventional Cardiology, and Interventional Cardiology- American Board Of Internal Medicine.

Dr. James Choi has been caring for Texas hearts since 2004. He is fellowship-trained in interventional cardiology. He is board-certified in internal medicine, cardiovascular disease, nuclear cardiology and interventional cardiology. Dr. Choi's areas of clinical interest and focus include cardiovascular disease in diabetic patients; highly complex cardiology interventions: left main coronary artery and chronic total occlusions; valvular heart interventions; structural heart interventions: ASD/PFO/Left atrial appendage closure; and peripheral vascular disease. He has published numerous articles and conducted clinical research on coronary stent implantation and chronic total occlusions as well as novel renal artery denervation treatment for resistant hypertension.Dr. Choi earned his medical degree from Northwestern University Medical School in Chicago, where he also completed his residency in internal medicine and fellowships in cardiology and interventional cardiology. He is the current medical director of Coronary, Renal and Structural Heart Technologies for the Baylor Research Institute in Dallas. He previously served as an associate professor in the Department of Internal Medicine at the Texas A&M Health Science Center College of Medicine in College Station and as the director of the Interventional Cardiology Fellowship at Baylor University Medical Center in Dallas.Dr. Choi is a Fellow of the American College of Cardiology and Society for Cardiovascular Angiography & Interventions. He currently chairs the DFW AngioClub and is a member of the American Heart Association, Texas Medical Association and Dallas County Medical Association. Dr. Choi has sat on numerous advisory boards, completed clinical research into various devices and cardiovascular procedures, and is active in the Korean-American medical community. Dr. Choi is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Angina, Heart Attack, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.